Evidence map›Paper›PMID 32521667›Full record

ReviewMicroorganisms2020

Crossing the Vacuolar Rubicon: Structural Insights into Effector Protein Trafficking in Apicomplexan Parasites.

Pascal F Egea

Open access · goldAbstract readReview
In one paragraph

Review in Microorganisms, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. bioRxiv : the preprint server for biology · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. DGPD: a knowledge database of dense granule proteins of the Apicomplexa.Database : the journal of biological databases and curation · 2022
    Article
  7. Article
  8. Plasmepsin-like Aspartyl Proteases inPathogens (Basel, Switzerland) · 2021
    Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. PV1 Protein fromInternational journal of molecular sciences · 2020
    Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Pascal F EgeaDepartment of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.
University of California, Los Angeles · US

Funding

Towards the reconstitution and a structure of the Plasmodium vacuolar transloconR21AI125983 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI EGEA, PASCAL FRANCOIS · 2016 to 2017
$406k
National Institute of Allergy and Infectious Diseases R21AI125983NIAID NIH HHS R21 AI125983
6 · The paper itself

Abstract

Apicomplexans form a large phylum of parasitic protozoa, including the genera

Indexed as

AAA+ chaperoneanti-parasitic drugApicomplexaClpB/HSP104effectormalariaMYRparasite–host interfaceparasitophorous vacuolePlasmodiumpore-forming membrane proteinproteasePTEXthioredoxinToxoplasmatranslocon–protein secretionvirulence factor

Identifiers

PMID32521667
PMCPMC7355975
OpenAlexW3033485143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.